[bionet.molbio.genbank] genbank funding

CZJ@CU.NIH.GOV (08/09/90)

It is nice to see all of the activity that Dan has generated on the
GenBank bboard after months of inactivity.  Clearly it is the
responsibility of NIH to do all of the things that Dan talked about
and unfortunately much more.  Despite the generous funds now available
to support GenBank and EMBL activities, there will never be enough
money to do all of the things that GenBank (or any other database)
should do.  With paylines hovering in the mid-teens and award rates in
the low twenties, it is hard to justify additional funds for databases
like GenBank.

Dan points to one thing that bears further discussion.
There is no question that GenBank received totally inadequate funding
during its initial contract period.  The result was a considerable lag
period in entering sequence data and unannotated entries.
Interestingly enough, the turnaround came with discussions about the
importance of the human genome project.  One very important fallout
was the realization of the importance of the sequence data and the
databases that stored them.  Without such discussions and exposure, I
doubt that such funding would have materialized.

Another important part of the discussions was the realization that a
significant part of the budget had to be put aside for database
issues.  Although this facet is recognized as important to the Genome
project, the arguement could have just as easily been made for any
other branch of science.  Nonetheless, when times get tight, it
becomes increasingly difficult to find funds for resources such as
databases as this necessarily mean that outstanding projects are not
funded.


Jim Cassatt

kristoff@genbank.BIO.NET (David Kristofferson) (08/10/90)

I think that it is time for some calm to be restored to the waters,
but I may do it by burning off the remaining gasoline.

Just as Dan mentioned that the LANL/IG staffs have been very busy, I
believe that this is true for the NIH staff as well.  My experience
having dealt with staff people at NIH during both BIONET and GenBank
is that they do try to do the right thing.  Unfortunately none of us
are experts in all of these areas, and thus NIH staffers, as well as
us, are always privileged to have the opinions of a variety of
experts.  This advice is sometimes contradictory and ocassionally
misinformed due to the simple fact that most "experts" are only expert
in one relevant area.  Biocomputing issues are definitely
interdisciplinary, and one might wonder how many people are used to
admitting when they themselves don't know an answer.  Experts
generally also tend to come from the bigger name schools and thus
these organizations have an additional political clout in the
resulting decisions.  Just as the databank staffers have to serve a
variety of different needs; the people at the NIH are undoubtedly put
in the position of trying to reconcile various warring factions.

This is reality.  Given this state of affairs, it should not be
surprising that collossal screw-ups can and do occur.  Timing of every
event that needs to take place in concert is usually off and people
are often left scrambling.  

In the event that we all become saints and everyone starts looking
after the good of the community instead of their own personal
interests, perhaps this problem will go away and everything will work
smoothly.  My recollection is that they tried an experiment like that
in the Soviet Union and it turned into a dismal failure.  If 1989
taught us anything, it should be that this confused battle of various
factions for resources may be the best we poor mortals can do.  Of
course, this is not a justification for gross negligence, but, knowing
the people involved in these issues, there is absolutlely no
justification for such a charge.  The scientific community, despite
all of its grousing, owes these people a far bigger debt than they
ever will realize, but generally rewards them with more abuse than
thanks.

So much for philosophy, now for specifics.

Dan, I did not miss your point about there not being funding for
everyone to develop their own software.  It is true that when the
databanks announce a change in format, they are not providing anything
other than a warning to the software community that the software
community must change.  One can definitely inquire about how the
software community is going to afford this change when grant money is
tight.  I would point out two items in response: 1) the Genome Office
announced in the NIH Guide which I posted about two weeks ago (and
which appeared again on the Genome newsgroup today) that software
money is now available for the Genome project.  That might be one
potential avenue.  Of course, one can respond that this money was not
there when the proposed feature table changes were planned.  2) It
appears from Roy Smith's message that there are people with funding
available now who would be interested in undertaking this task.  This
probably was the case when the feature table changes were announced,
too, if this discussion had occurred earlier.  Note that this
information came about ***because of the exchange on this
newsgroup!!***

With the benefit of hindsight I would suggest that, in the future,
discussions of format changes also take place on the various databank
newsgroups so that software developers can get together well in
advance and plan for the kind of cooperative efforts indicated in
recent messages.  Keeping the interested public abreast of
developments is very easy in this kind of forum.  I would dare say
that this whole incident could have been avoided if this approach was
taken earlier (not to predict that other snafus will not develop in
the future, of course 8-(.)

Dan, if this change sent you into a tizzy, just think what will happen
if the various Genome committees decide to implement entirely new
formats.  You can bet your Bazooka bubble gum that this will happen
eventually because technology continues to advance and change is
inevitable.

If only the world were static ... Parmenides, where are you when you
are truly needed 8-)!!!  

Enough; time to get back to work.
-- 
				Sincerely,

				Dave Kristofferson
				GenBank On-line Service Manager

				kristoff@genbank.bio.net